P57.02 Integration of Systemic / Tumor PD-L1 as a Predictive Biomarker of Clinical Outcome in Advanced NSCLC Patients Treated With Anti-PD-(L)1 Agents
Autor: | Anguera Palacios, G., Zamora Atenza, C., Riudavets Melià, M., Alserawan De Lamo, L., Sullivan, I., Barba Joaquín, A., Serra Lopez, J., Ortiz, M.A., Mulet, M., Vidal Alcorisa, S., Majem, M. |
---|---|
Zdroj: | In Journal of Thoracic Oncology October 2021 16(10) Supplement:S1136-S1137 |
Databáze: | ScienceDirect |
Externí odkaz: |